Analyst Consensus ?
ConsensusHold38 ratings
Bullish1436.9%
Neutral2360.5%
Bearish12.6%
1 unmapped firm rating excluded from the percentages.
FN2 Earnings Intelligence
Pfizer Inc. complete analyst coverage
Pfizer Inc. (PFE) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$25.25Current
$20Low
$39.24Average
$70High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Guggenheim | Buy | Buy | Maintain | Jul 13, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 13, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Jul 10, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 8, 2026 |
| HSBC | Hold | Buy | Downgrade | Jul 6, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Jul 6, 2026 |
| RBC Capital | Sector Perform | Underperform | Upgrade | Jun 10, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Apr 29, 2026 |
| UBS | Neutral | Neutral | Maintain | Apr 13, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Apr 10, 2026 |
| Argus Research | Buy | Hold | Upgrade | Mar 2, 2026 |
| Freedom Broker | Buy | Buy | Maintain | Feb 9, 2026 |
| Goldman Sachs | Neutral | Buy | Downgrade | Apr 8, 2025 |
| Truist Securities | Buy | Buy | Maintain | Dec 18, 2024 |
| Daiwa Capital | Outperform | Neutral | Upgrade | Aug 8, 2024 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 31, 2024 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 31, 2024 |
| TD Cowen | Market Perform | Outperform | Downgrade | Jan 4, 2024 |
| Jefferies | Buy | Hold | Upgrade | Oct 16, 2023 |
| Credit Suisse | Neutral | Outperform | Downgrade | Jun 29, 2023 |
| SVB Leerink | Market Perform | Market Perform | Maintain | Feb 1, 2023 |
| Atlantic Equities | Neutral | Neutral | Maintain | Feb 1, 2023 |
| Mizuho | Neutral | Neutral | Maintain | Dec 14, 2021 |
| DZ Bank | Buy | Hold | Upgrade | Feb 4, 2021 |
| Bernstein | Perform | Market Perform | Maintain | Nov 10, 2020 |
| Berenberg | Hold | Hold | Maintain | Sep 29, 2020 |
| Bank of America | Neutral | Buy | Downgrade | Jul 30, 2019 |
| Argus | Outperform | Neutral | Upgrade | Jan 31, 2019 |
| Leerink Swann | Market Perform | Market Perform | Maintain | Jan 31, 2018 |
| Societe Generale | Hold | Hold | Maintain | Apr 6, 2016 |
| SunTrust Robinson Humphrey | Neutral | Neutral | Maintain | Feb 16, 2016 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Oct 20, 2015 |
| PiperJaffray | Overweight | Overweight | Maintain | Jun 17, 2015 |
| Deutsche Bank | Buy | Buy | Maintain | Apr 28, 2015 |
| LBBW Research | Buy | Hold | Upgrade | Nov 14, 2013 |
| Standpoint Research | Sell | Hold | Downgrade | Jul 2, 2013 |
| Hilliard Lyons | Long Term Buy | Maintain | Jan 29, 2013 | |
| MKM Partners | Neutral | Buy | Downgrade | Nov 27, 2012 |
| ISI Group | Buy | Buy | Maintain | Apr 9, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $25.25. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| HSBC | Analyst unavailable | $28 | $24.32 | +10.9% | Jul 6, 2026 |
| UBS | Michael Yee | $27 | $26.34 | +6.9% | May 27, 2026 |
| Wolfe Research | Alexandria Hammond | $26 | $25.96 | +3.0% | May 14, 2026 |
| Morgan Stanley | Terence Flynn | $27 | $27.06 | +6.9% | Mar 17, 2026 |
| BMO Capital | Evan David Seigerman | $30 | $26.48 | +18.8% | Mar 9, 2026 |
| RBC Capital | Trung Huynh | $25 | $27.14 | -1.0% | Feb 24, 2026 |
| Barclays | Emily Field | $25 | $26.86 | -1.0% | Feb 19, 2026 |
| Daiwa | Narumi Nakagiri | $27 | $27.73 | +6.9% | Feb 12, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $27 | $25.88 | +6.9% | Jan 27, 2026 |
| UBS | Analyst unavailable | $25 | $25.43 | -1.0% | Jan 6, 2026 |
| Wolfe Research | Alexandria Hammond | $24 | $25.53 | -5.0% | Dec 17, 2025 |
| Morgan Stanley | Analyst unavailable | $28 | $25.89 | +10.9% | Dec 12, 2025 |
| HSBC | Rajesh Kumar | $29 | $25.33 | +14.9% | Dec 10, 2025 |
| Guggenheim | Analyst unavailable | $35 | $25.17 | +38.6% | Nov 24, 2025 |
| Goldman Sachs | Asad Haider | $26 | $24.22 | +3.0% | Nov 5, 2025 |
| Bernstein | Courtney Breen | $30 | $24.45 | +18.8% | Oct 31, 2025 |
| Morgan Stanley | Analyst unavailable | $32 | $25.24 | +26.7% | Oct 10, 2025 |
| UBS | Tim Anderson | $28 | $27.16 | +10.9% | Oct 1, 2025 |
| Cantor Fitzgerald | Carter Gould | $24 | $22.53 | -5.0% | Apr 22, 2025 |
| Truist Financial | Robyn Karnauskas | $32 | $25.89 | +26.7% | Dec 18, 2024 |
| Goldman Sachs | Chris Shibutani | $33 | $28.46 | +30.7% | Oct 30, 2024 |
| Bernstein | Courtney Breen | $32 | $29.67 | +26.7% | Oct 17, 2024 |
| Barclays | Carter Gould | $32 | $28.93 | +26.7% | Sep 25, 2024 |
| Daiwa | Narumi Nakagiri | $34 | $28.85 | +34.7% | Aug 7, 2024 |
| Wells Fargo | Mohit Bansal | $30 | $31.39 | +18.8% | Jul 31, 2024 |
| Goldman Sachs | Chris Shibutani | $34 | $31.39 | +34.7% | Jul 31, 2024 |
| Guggenheim | Vamil Divan | $36 | $30.72 | +42.6% | Jul 30, 2024 |
| Barclays | Carter Gould | $30 | $27.72 | +18.8% | Jul 10, 2024 |
| BMO Capital | Evan Seigerman | $36 | $29.6 | +42.6% | May 22, 2024 |
| Cantor Fitzgerald | Louise Chen | $45 | $26.97 | +78.2% | Feb 14, 2024 |
| Morgan Stanley | Thomas Yeh | $20 | $26.92 | -20.8% | Dec 14, 2023 |
| Morgan Stanley | Terence Flynn | $37 | $30.5 | +46.5% | Nov 27, 2023 |
| Morgan Stanley | Analyst unavailable | $45 | $43.84 | +78.2% | Feb 1, 2023 |
| Credit Suisse | Analyst unavailable | $50 | $43.59 | +98.0% | Feb 1, 2023 |
| Barclays | Analyst unavailable | $44 | $44.16 | +74.3% | Feb 1, 2023 |
| Atlantic Equities | Analyst unavailable | $46 | $44.16 | +82.2% | Feb 1, 2023 |
| Leerink Partners | Analyst unavailable | $48 | $44.16 | +90.1% | Feb 1, 2023 |
| Morgan Stanley | Analyst unavailable | $53 | $54.73 | +109.9% | Dec 14, 2022 |
| Goldman Sachs | Chris Shibutani | $60 | $53.37 | +137.6% | Dec 13, 2022 |
| Credit Suisse | Analyst unavailable | $55 | $48.33 | +117.8% | Nov 18, 2022 |
| Leerink Partners | David Risinger | $55 | $52.88 | +117.8% | May 23, 2022 |
| Wells Fargo | Mohit Bansal | $54.42 | $19.11 | +115.5% | May 10, 2022 |
| Wells Fargo | Mohit Bansal | $55 | $49.04 | +117.8% | May 9, 2022 |
| Morgan Stanley | Analyst unavailable | $52 | $49.68 | +105.9% | May 4, 2022 |
| Mizuho Securities | Vamil Divan | $55 | $49.07 | +117.8% | May 2, 2022 |
| Cantor Fitzgerald | Louise Chen | $75 | $53.12 | +197.0% | Apr 15, 2022 |
| Morgan Stanley | Terrance Flynn | $55 | $55.17 | +117.8% | Apr 10, 2022 |
| Citigroup | Andrew Baum | $57 | $55.17 | +125.7% | Apr 9, 2022 |
| Bank of America Securities | Geoff Meacham | $70 | $50.27 | +177.2% | Mar 12, 2022 |
| Barclays | Carter Gould | $54 | $51.7 | +113.9% | Feb 8, 2022 |
| Goldman Sachs | Chris Shibutani | $50 | $51.7 | +98.0% | Feb 8, 2022 |
| J.P. Morgan | Chris Schott | $57 | $51.7 | +125.7% | Feb 8, 2022 |
| BMO Capital | Evan Seigerman | $76 | $54.95 | +201.0% | Jan 15, 2022 |
| Bernstein | Aaron Gal | $65 | $56.22 | +157.4% | Jan 3, 2022 |
| Leerink Partners | Geoff Porges | $56 | $59.1 | +121.8% | Dec 22, 2021 |
| UBS | Colin Bristow | $60 | $54.78 | +137.6% | Dec 13, 2021 |
| Independent Research | Tobias Gottschalt | $54 | $49.8 | +113.9% | Nov 11, 2021 |
| Wolfe Research | Tim Anderson | $46 | $44.09 | +82.2% | Nov 3, 2021 |
| RBC Capital | Daniel Busby | $44 | $42.1 | +74.3% | Jul 29, 2021 |
| Argus Research | David Toung | $55 | $37.54 | +117.8% | Jun 1, 2021 |
Track every rating change on PFE the moment it posts. Free to start.
Start free